Stock Guru Profile News Blogs
Download MP3 Audio:
Download Windows Media:
http://www.stockguru.com/audio/sout10022007.wma
Rx Elite’s Sevoflurane marketing plan is well underway. Jonathan Houssian, President and Founder of Rx Elite explain in his interview with Talking Stocks that sevoflurane as a generic inhalable gas will not see a strong price erosion. (Reminder: Sevoflurane is the most widely used inhalable gas anesthesia in the world and RxElite is one of only three distributors in the United States.)
Why?
There are only three manufacturers of Sevoflurane in the world.
Why?
The process by which Sevoflurane is manufactured is expensive, complex, and it takes a significant amount of time to develop a facility which can manufacture Sevoflurane.
What does this tell us?
There will not be a significant price erosion in Sevoflurane as it comes on to the generic market. In this interview Jonathan Houssain explains the other two competitors would rather relinquish a part of the market share to RxElite than engage in a war of price competition. He expects a gradual and very modest price reduction for Sevoflurane.
Jonathan Houssian is pleased for RxElite to grab an eleven to fifteen percent share of the market estimated to be between $350M and $400M in the U.S. for distribution of Sevoflurane.
Significance Beyond Sevoflurane
Opthalmic Drops: Sevoflurane for RxElite serves as the model for other drugs in RxElite’s pipeline which include opthalmic products. In a nutshell — think Visine packaging — it comes in a sealed bottle. Opthalmic drops must be packaged in a sterile environment and sealed. This is a highly complex and expensive process. Generic opthalmic drops are in the pipeline. This product has the same barrier to entry that Sevoflurane has, because of its expensive packaging process!
Transdermal Patches: RxElite is developing a Fentanyl transdermal patch which again is a drug widely in demand but has a complicated developmental process.
With RxElite you see an immediate cash flow product and a powerful and well established business plan.
Listen to Johnathan Houssian’s interview for details!
Servoflurane
icon for podpress Standard Podcast: Hide Player | Play in Popup | Download
icon for podpress Windows Media: Download
Download MP3 Audio:
Download Windows Media:
http://www.stockguru.com/audio/sout10022007.wma
Investor Profile from Rx Elite
Source: RxElite Holdings, Inc.
RxElite Holdings, Inc.
Ph: (208) 288-5550
Toll Free: (800) 414-1901
Fax: (208) 288-1191 Investor Relations
Charlie Forshee, 215-885-4981
investorrelations@rxelite.com
Segue Ventures LLCAbout RxElite Holdings, Inc.: RxElite Holdings, Inc. develops, manufactures, and markets generic prescription drug products in specialty generic markets. These markets include products in the areas of anesthesia, sterile liquid dose drugs (including respiratory inhalation drugs, ophthalmics, and injectable drugs), and transdermal patch products.
Safe Harbor Statement This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 involving known and unknown risks, delays, and uncertainties that may cause the our actual results or performance to differ materially from those expressed or implied by these forward-looking statements. These risks, delays, and uncertainties include, but are not limited to: risks associated with the uncertainty of future financial results, our reliance on our sole supplier, the limited diversification of our product offerings, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company’s filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.
Disclosure: Pentony Enterprises LLC was compensated $18,000.00. Pentony Enterprises LLC is not a registered investment adviser or broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.
Disclosure: StockGuru.com is owned and operated by Pentony Enterprises LLC,9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com.
Bookmark to:
Add ‘StockGuru Blog: RxElite Holdings (SOUT) – Hear the Man with the Plan for RxElite’ to Del.icio.usAdd ‘StockGuru Blog: RxElite Holdings (SOUT) – Hear the Man with the Plan for RxElite’ to diggAdd ‘StockGuru Blog: RxElite Holdings (SOUT) – Hear the Man with the Plan for RxElite’ to FURLAdd ‘StockGuru Blog: RxElite Holdings (SOUT) – Hear the Man with the Plan for RxElite’ to blinklistAdd ‘StockGuru Blog: RxElite Holdings (SOUT) – Hear the Man with the Plan for RxElite’ to redditAdd ‘StockGuru Blog: RxElite Holdings (SOUT) – Hear the Man with the Plan for RxElite’ to Feed Me LinksAdd ‘StockGuru Blog: RxElite Holdings (SOUT) – Hear the Man with the Plan for RxElite’ to TechnoratiAdd ‘StockGuru Blog: RxElite Holdings (SOUT) – Hear the Man with the Plan for RxElite’ to Yahoo My WebAdd ‘StockGuru Blog: RxElite Holdings (SOUT) – Hear the Man with the Plan for RxElite’ to NewsvineAdd ‘StockGuru Blog: RxElite Holdings (SOUT) – Hear the Man with the Plan for RxElite’ to SocializerAdd ‘StockGuru Blog: RxElite Holdings (SOUT) – Hear the Man with the Plan for RxElite’ to Ma.gnoliaAdd ‘StockGuru Blog: RxElite Holdings (SOUT) – Hear the Man with the Plan for RxElite’ to Stumble UponAdd ‘StockGuru Blog: RxElite Holdings (SOUT) – Hear the Man with the Plan for RxElite’ to Google Bookmarks
Add ‘StockGuru Blog: RxElite Holdings (SOUT) – Hear the Man with the Plan for RxElite’ to RawSugarAdd ‘StockGuru Blog: RxElite Holdings (SOUT) – Hear the Man with the Plan for RxElite’ to SquidooAdd ‘StockGuru Blog: RxElite Holdings (SOUT) – Hear the Man with the Plan for RxElite’ to SpurlAdd ‘StockGuru Blog: RxElite Holdings (SOUT) – Hear the Man with the Plan for RxElite’ to BlinkBitsAdd ‘StockGuru Blog: RxElite Holdings (SOUT) – Hear the Man with the Plan for RxElite’ to NetvouzAdd ‘StockGuru Blog: RxElite Holdings (SOUT) – Hear the Man with the Plan for RxElite’ to RojoAdd ‘StockGuru Blog: RxElite Holdings (SOUT) – Hear the Man with the Plan for RxElite’ to BlogmarksAdd ‘StockGuru Blog: RxElite Holdings (SOUT) – Hear the Man with the Plan for RxElite’ to ShadowsAdd ‘StockGuru Blog: RxElite Holdings (SOUT) – Hear the Man with the Plan for RxElite’ to SimpyAdd ‘StockGuru Blog: RxElite Holdings (SOUT) – Hear the Man with the Plan for RxElite’ to Co.mmentsAdd ‘StockGuru Blog: RxElite Holdings (SOUT) – Hear the Man with the Plan for RxElite’ to ScuttleAdd ‘StockGuru Blog: RxElite Holdings (SOUT) – Hear the Man with the Plan for RxElite’ to BloglinesAdd ‘StockGuru Blog: RxElite Holdings (SOUT) – Hear the Man with the Plan for RxElite’ to Tailrank